#Clinical Trials
20Nov2026
Industry News
Thermo Fisher Clario Acquisition Reshapes Trial Data Buying
Thermo Fisher Clario acquisition closed at $8.875B and puts endpoint trial data inside a major U.S. lab supplier.
Continue readingAn independent U.S. publication tracking science and lab supply news, buying guidance, and practical knowledge.
The Lab LedgerIndustry News
Thermo Fisher Clario acquisition closed at $8.875B and puts endpoint trial data inside a major U.S. lab supplier.
Continue reading